IBDEI279 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,36925,1,3,0)
 ;;=3^Chronic leukemia of unspecified cell type, in relapse
 ;;^UTILITY(U,$J,358.3,36925,1,4,0)
 ;;=4^C95.12
 ;;^UTILITY(U,$J,358.3,36925,2)
 ;;=^5001855
 ;;^UTILITY(U,$J,358.3,36926,0)
 ;;=D46.9^^169^1862^51
 ;;^UTILITY(U,$J,358.3,36926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36926,1,3,0)
 ;;=3^Myelodysplastic syndrome, unspecified
 ;;^UTILITY(U,$J,358.3,36926,1,4,0)
 ;;=4^D46.9
 ;;^UTILITY(U,$J,358.3,36926,2)
 ;;=^334031
 ;;^UTILITY(U,$J,358.3,36927,0)
 ;;=C95.90^^169^1862^39
 ;;^UTILITY(U,$J,358.3,36927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36927,1,3,0)
 ;;=3^Leukemia, unspecified not having achieved remission
 ;;^UTILITY(U,$J,358.3,36927,1,4,0)
 ;;=4^C95.90
 ;;^UTILITY(U,$J,358.3,36927,2)
 ;;=^5001856
 ;;^UTILITY(U,$J,358.3,36928,0)
 ;;=C95.91^^169^1862^41
 ;;^UTILITY(U,$J,358.3,36928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36928,1,3,0)
 ;;=3^Leukemia, unspecified, in remission
 ;;^UTILITY(U,$J,358.3,36928,1,4,0)
 ;;=4^C95.91
 ;;^UTILITY(U,$J,358.3,36928,2)
 ;;=^5001857
 ;;^UTILITY(U,$J,358.3,36929,0)
 ;;=C95.92^^169^1862^40
 ;;^UTILITY(U,$J,358.3,36929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36929,1,3,0)
 ;;=3^Leukemia, unspecified, in relapse
 ;;^UTILITY(U,$J,358.3,36929,1,4,0)
 ;;=4^C95.92
 ;;^UTILITY(U,$J,358.3,36929,2)
 ;;=^5001858
 ;;^UTILITY(U,$J,358.3,36930,0)
 ;;=D72.9^^169^1862^35
 ;;^UTILITY(U,$J,358.3,36930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36930,1,3,0)
 ;;=3^Disorder of white blood cells, unspecified
 ;;^UTILITY(U,$J,358.3,36930,1,4,0)
 ;;=4^D72.9
 ;;^UTILITY(U,$J,358.3,36930,2)
 ;;=^5002381
 ;;^UTILITY(U,$J,358.3,36931,0)
 ;;=D75.1^^169^1862^59
 ;;^UTILITY(U,$J,358.3,36931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36931,1,3,0)
 ;;=3^Secondary polycythemia
 ;;^UTILITY(U,$J,358.3,36931,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,36931,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,36932,0)
 ;;=D75.9^^169^1862^34
 ;;^UTILITY(U,$J,358.3,36932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36932,1,3,0)
 ;;=3^Disease of blood and blood-forming organs, unspecified
 ;;^UTILITY(U,$J,358.3,36932,1,4,0)
 ;;=4^D75.9
 ;;^UTILITY(U,$J,358.3,36932,2)
 ;;=^5002393
 ;;^UTILITY(U,$J,358.3,36933,0)
 ;;=C7A.010^^169^1862^42
 ;;^UTILITY(U,$J,358.3,36933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36933,1,3,0)
 ;;=3^Malignant carcinoid tumor of the duodenum
 ;;^UTILITY(U,$J,358.3,36933,1,4,0)
 ;;=4^C7A.010
 ;;^UTILITY(U,$J,358.3,36933,2)
 ;;=^5001359
 ;;^UTILITY(U,$J,358.3,36934,0)
 ;;=C7A.011^^169^1862^44
 ;;^UTILITY(U,$J,358.3,36934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36934,1,3,0)
 ;;=3^Malignant carcinoid tumor of the jejunum
 ;;^UTILITY(U,$J,358.3,36934,1,4,0)
 ;;=4^C7A.011
 ;;^UTILITY(U,$J,358.3,36934,2)
 ;;=^5001360
 ;;^UTILITY(U,$J,358.3,36935,0)
 ;;=C7A.012^^169^1862^43
 ;;^UTILITY(U,$J,358.3,36935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36935,1,3,0)
 ;;=3^Malignant carcinoid tumor of the ileum
 ;;^UTILITY(U,$J,358.3,36935,1,4,0)
 ;;=4^C7A.012
 ;;^UTILITY(U,$J,358.3,36935,2)
 ;;=^5001361
 ;;^UTILITY(U,$J,358.3,36936,0)
 ;;=C93.30^^169^1862^38
 ;;^UTILITY(U,$J,358.3,36936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36936,1,3,0)
 ;;=3^Juvenile myelomonocytic leukemia,no remission
 ;;^UTILITY(U,$J,358.3,36936,1,4,0)
 ;;=4^C93.30
 ;;^UTILITY(U,$J,358.3,36936,2)
 ;;=^5001825
 ;;^UTILITY(U,$J,358.3,36937,0)
 ;;=C93.31^^169^1862^37
 ;;^UTILITY(U,$J,358.3,36937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36937,1,3,0)
 ;;=3^Juvenile myelomonocytic leukemia,in remission
 ;;^UTILITY(U,$J,358.3,36937,1,4,0)
 ;;=4^C93.31
